Medication info
Telmisartan Plus Tablets 40/12.5 mg

Telmisartan Plus Tablets 40/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Ceil Pharmaceutical Co., Ltd.
Appearance
White or almost white, round, biconvex tablets.
Packaging
30 tablets (10 tablets/PTP x 3), 100 tablets/bottle
Approval status
Active

MFDS item code 201300146 · Approved 2013.01.08 · Insurance code 645403930

Summary

Main use
Treatment of essential hypertension not adequately controlled with telmisartan monotherapy
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a beverage, with or without food. Before switching to this drug, which contains fixed doses of each component, it is recommended to adjust the dose of each component individually for the patient. When clinically appropriate, a direct switch from monotherapy to this drug may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this drug. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this drug to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Use this drug with caution in patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this drug per day. Do not administer this drug to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be used with caution in patients with impaired hepatic function. Older adults No dose adjustment is necessary.
Child dose
The safety and efficacy of this drug have not been established in children under 18 years of age.

Ingredients

Manufacturer
Ceil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with telmisartan monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension when blood pressure is not adequately controlled by monotherapy with telmisartan alone. It helps effectively control blood pressure and reduce the risk of cardiovascular diseases.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a beverage, with or without food. Before switching to this drug, which contains fixed doses of each component, it is recommended to adjust the dose of each component individually for the patient. When clinically appropriate, a direct switch from monotherapy to this drug may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this drug. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this drug to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Use this drug with caution in patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this drug per day. Do not administer this drug to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be used with caution in patients with impaired hepatic function. Older adults No dose adjustment is necessary.

Child dose

The safety and efficacy of this drug have not been established in children under 18 years of age.

Precautions

This medication can pose a serious risk to the fetus during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women. Patients who are allergic to any of the ingredients in this medication or those with certain liver or kidney diseases should not take this medication. Elderly patients, those with hyperkalemia, or patients with liver disorders should consult a physician before use and exercise caution. This medication lowers blood pressure, so it is important to be cautious of symptoms such as dizziness or fainting due to excessively low blood pressure. The hydrochlorothiazide component may cause electrolyte imbalances, so regular monitoring of serum potassium, sodium, etc., is necessary. Care should be taken to avoid excessive sunlight exposure while on this medication, and any skin rash or unusual reactions should be reported to a physician immediately. Since there may be interactions with other medications, it's crucial to inform your doctor or pharmacist of any current medications you are taking and seek advice. In case of overdose, symptoms such as hypotension, electrolyte imbalances, and dehydration may occur, necessitating an immediate visit to a medical institution. The safety and efficacy of this medication have not been established in children, so use is not recommended, and for the elderly, blood pressure-lowering effects should be carefully monitored during administration. This medication should be kept out of the reach of children, and it is advisable to take it immediately after opening the packaging.

Side effects

  • bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorder
Show 129 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • abdominal distension
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • liver disorder
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasm
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • increased liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • angioedema
  • eczema
  • drug rash
  • toxic epidermal necrolysis
  • pain in joints
  • renal dysfunction
  • weakness
  • influenza-like illness
  • increased blood creatinine
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • sialadenitis
  • hypomagnesemia
  • hyperlipidemia
  • decreased appetite
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • headache
  • yellow vision
  • acute myopia
  • closed-angle glaucoma
  • choroidal exudate
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • jaundice
  • bile stagnation
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal dysfunction
  • weakness
  • fever
  • dizziness
  • diarrhea
  • cough
  • itching
  • myalgia
  • headache
  • floating sensation
  • tremors of lips and hands
  • hypersensitivity
  • periodontal disease
  • chapped lips
  • decreased vision
  • hypoglycemia
  • intestinal angioedema
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • fatigue
  • weight loss
  • proteinuria
  • facial flushing
  • lethargy
  • fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C to preserve its effectiveness.

Appearance and packaging

Appearance

White or almost white, round, biconvex tablets.

Package unit

30 tablets (10 tablets/PTP x 3), 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.